Načítá se...

Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway

Lung cancer is one of the most frequent malignant tumors, with the top morbidity and mortality, in China. Calpain family regulates cellular processes including migration and invasion. However, the role of Calpain-2 in non-small cell lung cancer (NSCLC) remains unclear. This study aims to explore the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Biol Sci
Hlavní autoři: Xu, Fengkai, Gu, Jie, Lu, Chunlai, Mao, Wei, Wang, Lin, Zhu, Qiaoliang, Liu, Zhonghe, Chu, Yiwei, Liu, Ronghua, Ge, Di
Médium: Artigo
Jazyk:Inglês
Vydáno: Ivyspring International Publisher 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6329934/
https://ncbi.nlm.nih.gov/pubmed/30662353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.28834
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!